Bernardo Bancalari

ORCID: 0000-0002-8803-1519
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer and Skin Lesions
  • Nonmelanoma Skin Cancer Studies
  • Hedgehog Signaling Pathway Studies
  • Sarcoma Diagnosis and Treatment
  • Melanoma and MAPK Pathways
  • Chemotherapy-related skin toxicity
  • Oral Health Pathology and Treatment
  • Cutaneous Melanoma Detection and Management
  • Vascular Tumors and Angiosarcomas
  • Skin Diseases and Diabetes
  • Celiac Disease Research and Management
  • Biomedical Research and Pathophysiology
  • Histiocytic Disorders and Treatments
  • Pediatric Urology and Nephrology Studies
  • Renal and Vascular Pathologies
  • Dermatologic Treatments and Research
  • Facial Rejuvenation and Surgery Techniques
  • Vascular Malformations and Hemangiomas
  • Tumors and Oncological Cases
  • Renal cell carcinoma treatment
  • Advanced Biosensing Techniques and Applications
  • Neonatal Health and Biochemistry
  • Hormonal Regulation and Hypertension
  • Soft tissue tumor case studies
  • Dermatological and Skeletal Disorders

Fundación Instituto Valenciano de Oncología
2016-2021

Hospital Infantil Universitario Niño Jesús
2019

Hospital Regional de Concepción
1954

Hôpital de la Conception
1949

Small series of ultrasound findings in dermatofibrosarcoma protuberans (DFSP) have been published, but the usefulness this technique as a preoperative planning tool for tumor resection has not studied.We retrospectively reviewed patients with DFSP at our hospital that underwent examination. Depth invasion was evaluated by and histopathology. Accuracy assessing depth estimated.Thirty histopathologically confirmed DFSPs were studied. Classic finger-like projections observed 73.3% cases. A...

10.1111/srt.13003 article EN Skin Research and Technology 2021-01-17

Small renal mass incidentally diagnosed are common findings nowadays due to the widespread of imaging. Renal biopsy is still underutilized by urologists its non-diagnostic rates. Confocal microscopy allows for rapid imaging fresh tissue samples. We report feasibility using confocal technology determining quality core at on 4 consecutive cases our institution.

10.23736/s0393-2249.19.03627-0 article EN Minerva Urologica e Nefrologica 2020-02-01

There are no large series describing cutaneous histologic changes during treatment with vismodegib in locally advanced basal cell carcinoma (BCC).To analyze skin biopsy specimens from patients BCC treated vismodegib.A descriptive, retrospective study of between June 2012 and December 2017 at the Instituto Valenciano de Oncología, Spain. Nineteen were biopsied before vismodegib, we compared observed.Seven (37%) achieved complete response, which was characterized by replacement tumor stroma a...

10.1097/dad.0000000000001384 article EN American Journal of Dermatopathology 2019-08-21

Abstract Papillary hemangioma (PH) is a rare, benign, vascular tumor that usually appears on the scalp and face reported most frequently in adults. We present pediatric case of PH provide sonographic features may assist establishing diagnosis.

10.1111/pde.14048 article EN Pediatric Dermatology 2019-11-29

La necrobiosis lipoídica (NL) es una enfermedad granulomatosa crónica poco frecuente para la que existen multitud de tratamientos disponibles. No obstante, estos ofrecen habitualmente mínimos e inconsistentes resultados. En algunas publicaciones se describe el tratamiento con terapia fotodinámica (TFD) como segunda línea en casos refractarios, resultados variables. Comunicamos 4 NL tratados satisfactoriamente TFD convencional MAL y BF-200 ALA. Las pacientes eran mujeres afectas diabetes...

10.1016/j.ad.2019.01.022 article ES cc-by-nc-nd Actas Dermo-Sifiliográficas 2020-06-20

Vismodegib is the first selective Hedgehog inhibitor approved for treatment of locally advanced and metastatic basal cell carcinoma (BCC). In this article, we describe our experience with use drug to treat and/or multiple BCCs at a cancer center over 5 years. We analyzed following variables: patient age sex; tumor location, size, type, characteristics; time since onset; primary or recurrent status; duration treatment; response (complete, partial, stabilization, absence response); adverse...

10.1016/j.adengl.2018.09.010 article ES cc-by-nc-nd Actas Dermo-Sifiliográficas 2018-10-05

Bancalari, Bernardoa; Algarra, María A.b; Llombart, Beatriza; Nagore, Eduardoa; Soriano, Virtudesb; Sanmartín, Onofrea; Requena, Celiaa Author Information

10.1097/cmr.0000000000000602 article EN Melanoma Research 2019-07-21

Most relapses in melanoma patients occur during the first five years after diagnosis. Identifying characteristics associated with recurrence this period could help delineate guidelines, specifically for follow-up protocols. Objectives: The aim of study was to identify prognostic factors relapse and death caused by who have been disease-free years. We designed a longitudinal retrospective cohort Stage I/II cutaneous free disease more than (late cohort). Prognostic melanoma-specific survival...

10.1684/ejd.2021.4022 article EN European Journal of Dermatology 2021-04-01

En los ultJmo-s 4 anos ban pasado por nuestra Secciou Pcdiatria

10.4067/s0370-41061949001100003 article ES Revista chilena de pediatría 1949-11-01

10.4067/s0370-41061954001000003 article ES Revista chilena de pediatría 1954-10-01

ES freCUCnte onCOntiar en la literatu-barazo de termino

10.4067/s0370-41061949001100004 article ES Revista chilena de pediatría 1949-11-01

Necrobiosis lipoidica is a rare chronic granulomatous disease. Multiple treatment approaches are available, but results generally minimal and inconsistent. Some publications report variable with photodynamic therapy (PDT) as second line of for refractory cases. We 4 cases necrobiosis treated satisfactorily conventional PDT using methyl aminolevulinate or 5-aminolevulinic acid BF-200 the photosensitizing agent. All patients were women diabetes mellitus who had undergone at least twice in...

10.1016/j.adengl.2020.08.012 article ES cc-by-nc-nd Actas Dermo-Sifiliográficas 2020-08-07
Coming Soon ...